Lobby organisation
LEO Pharma A/S
Business / industry · Health & pharma · HQ: Denmark · Transparency Register entry
As of 9 September 2026, LEO Pharma A/S appears in 4 declared MEP meetings (4 different MEPs), most often with European Conservatives & Reformists.
In their own words
“LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Headquartered in Denmark, LEO Pharma…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 4 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2026–2026. Bar length is relative to its busiest year (4 in 2026). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 4 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 24 Jun 2026 | Henrik Dahl | Medical devices |
| 9 Jun 2026 | Kristoffer Storm | EU Biotech Act |
| 22 Apr 2026 | Stine Bosse | Biotech Act |
| 3 Mar 2026 | Laurent Castillo | Europe de la santé |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.